Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Azathioprine Therapy Guidance

Key Drug Interactions and Contraindications

  • The British Association of Dermatologists recommends avoiding Allopurinol due to severe myelosuppression, requiring a 65-75% dose reduction if combination is necessary 4, 5, 6
  • The British Association of Dermatologists advises against combining azathioprine with Sulfasalazine, as it inhibits TPMT activity and potentiates toxicity 4, 5
  • The British Association of Dermatologists notes that Warfarin may impair anticoagulant effect 4, 5
  • The British Association of Dermatologists warns of increased risk of serious hematological toxicity when azathioprine is combined with myelosuppressive drugs like penicillamine or co-trimoxazole 4, 5
  • The British Association of Dermatologists cautions that ACE inhibitors may induce severe leucopenia 4, 5
  • The British Association of Dermatologists states that live vaccines are contraindicated 4, 5
  • The British Association of Dermatologists lists hypersensitivity to azathioprine or 6-mercaptopurine as an absolute contraindication 2, 3
  • The British Association of Dermatologists considers very low or absent TPMT activity an absolute contraindication 1, 7, 8, 9, 10
  • The British Association of Dermatologists notes severe infections as an absolute contraindication 2, 3
  • The British Association of Dermatologists states that severely impaired hepatic or bone marrow function is an absolute contraindication 2, 3
  • The British Association of Dermatologists lists pancreatitis as an absolute contraindication 2, 3

Hepatotoxicity Monitoring Context

  • The British Association of Dermatologists recommends baseline liver function tests before starting azathioprine therapy 2, 3, 11
  • The British Association of Dermatologists advises weekly liver function tests for the first 4 weeks of azathioprine therapy 11
  • The British Association of Dermatologists suggests monthly monitoring until maintenance dose is achieved 11
  • The British Association of Dermatologists recommends every 3 months monitoring once a stable dose is achieved 2, 11
  • Patients should seek urgent medical attention for signs of liver impairment, including jaundice, as recommended by the British Association of Dermatologists 1, 5

Important Monitoring Parameters

  • The British Association of Dermatologists recommends that patients on azathioprine report immediately any unexplained bruising or bleeding 1
  • The British Association of Dermatologists advises patients to report sore throat or signs of infection immediately 1
  • The British Association of Dermatologists recommends immediate reporting of high fever 5
  • The British Association of Dermatologists suggests that patients report jaundice immediately 11
  • The British Association of Dermatologists warns patients to seek immediate medical attention for sudden onset abdominal pain, possible pancreatitis 4